Asthma Therapeutics Market Size, Scope, Trends, Top Companies Share, Growth and Opportunities Forecast to 2026

According to IMARC Group’s latest report, titled “Asthma Therapeutics Market Size, Trends, Share, Growth, Opportunity and Forecast 2021-2026”, the global asthma therapeutics market grew at a CAGR of around 4% during 2014-2019 and reached a value of US$ 17.6 Billion in 2020. Looking forward, IMARC Group expects the global market to continue its moderate growth during 2021-2026.

Asthma therapeutics include a group of pharmaceutical drugs that are primarily used for treating asthma. The drugs help in mitigating the symptoms of the respiratory disease, which usually gets triggered by exposure to various outdoor and indoor causative agents, including dust, allergens, pollutants, etc. Asthma therapeutics generally include bronchodilators and anti-inflammatory drugs, such as long-acting beta-agonists (LABA), methylxanthine, immunomodulators, corticosteroids, leukotriene modifiers, etc. These drugs aid in expansion of air passage into the lungs, which further enables the proper movement of air to enhance the breathing process. Asthma therapeutics drugs are usually administered via inhalers or nebulizers and are adopted in quick-relief medications and long-term asthma control therapies.

Get a PDF sample of this report for more detailed market insights: https://www.imarcgroup.com/asthma-therapeutics-market/requestsample

The rising prevalence of asthma due to the growing air pollution levels is currently propelling the adoption of asthma therapeutics. Additionally, the increasing consumer awareness towards the easy availability of effective asthma therapeutics is also catalyzing the market growth. Furthermore, the emergence of combination therapies for treating respiratory diseases, such as asthma, is driving the demand for asthma therapeutics. Numerous pharma companies are constantly focusing on clinical trials of pipeline asthma drugs with higher efficacy and prolonged effect. Several other factors, including the growing healthcare expenditures, continuous upgradation of healthcare infrastructures, extensive R&D activities in the medical sector, etc., are expected to further bolster the global asthma therapeutics market in the coming years.

Key Market Segmentation:

IMARC Group provides an analysis of the key trends in each sub-segment of the global asthma therapeutics market report, along with forecasts for growth at the global, regional and country level from 2021-2026. Our report has categorized the market on the basis of region, drugs class, product type, treatment type and route of administration.

Breakup by Drug Class:

Anti-Inflammatory Drugs
Bronchodilators
Combination Therapies
Breakup by Product Type:

Inhalers
Dry Powder Inhalers
Metered Dose Inhalers
Soft Mist Inhalers
Nebulizers
Pneumatic Nebulizers
Ultrasonic Nebulizers
Mesh Nebulizers
Breakup by Treatment Type:

Quick-Relief Medications
Long-Term Asthma Control Medications
Breakup by Route of Administration:

Inhalation
Oral
Parenteral
Breakup by Region:

North America
Asia Pacific
Europe
Latin America
Middle East and Africa
Explore full report with table of contents: https://www.imarcgroup.com/asthma-therapeutics-market

Competitive Landscape:

The report has also analysed the competitive landscape of the market with some of the key players being AstraZeneca, Abbott, Amgen Inc., Biogen Inc., Boehringer Ingelheim GmbH, F. Hoffmann-La Roche AG, GlaxoSmithKline plc., Merck & Co. Inc., Novartis AG, Sunovion Pharmaceuticals Inc. (Dainippon Sumitomo Pharma Co. Ltd.) and Teva Pharmaceutical Industries Ltd.

Contact US: IMARC Group
30 N Gould St, Ste R
Sheridan, WY 82801, USA
Website: https://www.imarcgroup.com/
Email: sales@imarcgroup.com
USA: +1-631-791-1145
Follow us on twitter: @imarcglobal
Linkedin: https://www.linkedin.com/company/imarc-group

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

This release was published on openPR.